highflyer
Well-known member
- Jan 21, 2016
- 2,553
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
As scientists at the Jenner Institute prepare for mass clinical trials, new tests show their vaccine to be effective in monkeys.
In the worldwide race for a vaccine to stop the coronavirus, the laboratory sprinting fastest is at Oxford University.
Most other teams have had to start with small clinical trials of a few hundred participants to demonstrate safety. But scientists at the university’s Jenner Institute had a head start on a vaccine, having proved in previous trials that similar inoculations — including one last year against an earlier coronavirus — were harmless to humans.
That has enabled them to leap ahead and schedule tests of their new coronavirus vaccine involving more than 6,000 people by the end of next month, hoping to show not only that it is safe, but also that it works.
The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September — at least several months ahead of any of the other announced efforts — if it proves to be effective.
Now, they have received promising news suggesting that it might.
Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic — exposure that had consistently sickened other monkeys in the lab. But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test.
“The rhesus macaque is pretty much the closest thing we have to humans,” Dr. Munster said, noting that scientists were still analyzing the result. He said he expected to share it with other scientists next week and then submit it to a peer-reviewed journal.
https://www.nytimes.com/2020/04/27/...ate-oxford.html#click=https://t.co/PZ1mQcDPwB
Nothing is certain, fingers crossed, etc.
But, apart from the very obvious ray of hope in terms of a vaccine, there are so many other reasons to celebrate this story.
British, not-for-profit outfit, started by scientists that wanted to focus on vaccines that affect poor countries and thus have less commercial potential. Innovative work, well ahead of the game, and now having government money thrown at them. Investing across the gobe to be ready to scale up production just in case it works. Refusing to grant exclusive licences to ensure the benefits are spread widely and 'nobody is going to make a lot of money from this'.
The one double edged sword is that trials may be a problem because not enough people are still being infected in the UK, making it hard to get the statistical certainty needed to prove it works. I assume there will always be places somewhere in the world where infection rates are high enough, but guess it takes longer to set up trials in new places.